ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,071.63
0.02%
US Tech 100
16,868.40
-0.79%
Dow Jones
38,460.92
-0.11%
Brent Oil
87.195
-0.03%
Bitcoin
64,441.08
0.25%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Clene Inc (CLNN) Quote

Clene Inc

Clene Inc (CLNN)

NASDAQ
0.337
0.0019
(0.57%)
Closed April 24 4:00PM
Delayed by 15 minutes
0.338
0.001
(0.30%)
After Hours: 7:54PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.338
Bid
0.33
Ask
0.338
Volume
315,189
0.325 Day's Range 0.34
0.25 52 Week Range 1.09
Market Cap
43.666M
Previous Close
0.3351
Open
0.3384
Last Trade
8876
@
0.338
(formt)
Last Trade Time
Financial Volume
$ 104,044
VWAP
0.330099
Average Volume (3m)
955,252
Shares Outstanding
128,430,098
Dividend Yield
-
PE Ratio
-0.88
Earnings Per Share (EPS)
-0.39
Revenue
654k
Net Profit
-49.5M

About Clene Inc

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.clene.com
Headquarters
Dover, Delaware, USA
Founded
1970
Clene Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CLNN. The last closing price for Clene was $0.34. Over the last year, Clene shares have traded in a share price range of $ 0.25 to $ 1.09.

Clene currently has 128,430,098 shares outstanding. The market capitalization of Clene is $43.67 million. Clene has a price to earnings ratio (PE ratio) of -0.88.

CLNN Latest News

More News

IBN Announces First in Human Podcast Featuring Clene Inc. CEO Rob Etherington

LOS ANGELES, March 19, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies with the investment community, today announces...

March 19 2024
GlobeNewswire Inc.

Form 8-K - Current report

February 29 2024
Edgar (US Regulatory)

Form 8-K - Current report

February 22 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

February 14 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

February 13 2024
Edgar (US Regulatory)

Form 8-K - Current report

January 31 2024
Edgar (US Regulatory)

Form 8-K - Current report

January 08 2024
Edgar (US Regulatory)

Form 8-K - Current report

December 21 2023
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.022-6.111111111110.360.37180.30726542440.33912983CS
4-0.082-19.52380952380.420.460.30414647370.33988965CS
12-0.182-350.520.53260.3049552520.38664477CS
26-0.132-28.0851063830.470.60.259118720.37998894CS
52-0.652-65.85858585860.991.090.256770090.49832784CS
156-9.587-96.59445843839.92517.820.255421102.55377596CS
260-9.212-96.46073298439.5517.820.255114272.9569831CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.43
(182.34%)
220.5M
AIREreAlpha Tech Corporation
$ 1.14
(88.74%)
35.42M
BOFBranchOut Food Inc
$ 2.0144
(72.17%)
107.44M
LICNLichen China Limited
$ 0.94
(67.86%)
15.08M
AMSTAmesite Inc
$ 3.31
(65.50%)
70.3M
NCINeo Concept International Group Holdings Ltd
$ 2.33
(-75.47%)
8.33M
GCTKGlucoTrack Inc
$ 0.466
(-38.68%)
1.7M
ISUNiSun Inc
$ 0.0922
(-38.12%)
9.79M
VAXXVaxxinity Inc
$ 0.1326
(-33.70%)
4.95M
EVOEvotec SE
$ 5.2199
(-31.77%)
1.55M
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.43
(182.34%)
220.5M
TSLATesla Inc
$ 162.13
(12.06%)
181.24M
SQQQProShares UltraPro Short QQQ
$ 11.81
(-0.84%)
148.21M
BOFBranchOut Food Inc
$ 2.0144
(72.17%)
107.44M
NKLANikola Corporation
$ 0.6206
(-2.31%)
80.82M

CLNN Discussion

View Posts
Awl416 Awl416 1 week ago
Pop
👍️0
Monksdream Monksdream 2 months ago
CLNN 10Q due March 8
👍️0
Monksdream Monksdream 4 months ago
CLNN new 52 week low
👎️ 1 🤡 1 🩳 1
scotsand scotsand 4 months ago
Running now. Join the fun.
👍️0
Monksdream Monksdream 6 months ago
CLNN new 52 week low
👍️0
Monksdream Monksdream 7 months ago
CLNN new 52 week low
👍️0
Monksdream Monksdream 7 months ago
CLNN new 52 week low
👍️0
Monksdream Monksdream 7 months ago
CLNN new 52 week low
👍️0
Louman Louman 8 months ago
7 analyst ratings still 100% buy. PT $4-$10.
👍️0
Louman Louman 10 months ago
$3.4 million in inside buys between 6-20 and 6-27. Price target $5. 7 analyst ratings 100% buy
👍️0
bwrbad bwrbad 10 months ago
THIS IS ONE ISSUE DO NOT MISS
👍️0
JUST 10-11-12 JUST 10-11-12 1 year ago
i.ll take 12 bucks per share
👍️0
CapGainsman CapGainsman 1 year ago
EF Hutton initiates coverage today on CLNN with a $13 price target. And HC Wainwright has reiterated a $15 price target twice in recent days. And CLNN has reported positive trial results in recent weeks. Other than there appear to be a bunch of pesky shorters involved, this seems like a gift down here. Also, CLNN will be presenting in the upcoming Roth's 35th annual healthcare conference.
👍️0
81vette 81vette 1 year ago
12mms stacked,bid/demand growing,13k@1.21,could pop any min now
👍️0
81vette 81vette 1 year ago
Over 3m shares short,some covering has to happen
👍️0
81vette 81vette 1 year ago
Day1 of higher high/higher low,gotta love nabbing the very beginning of bulls being turned loose,market is manipulated the worst in 20 years,mms/banks have gotten ridiculously greedy,can’t beat em/join um is my motto
👍️0
81vette 81vette 1 year ago
My Scanner telling me buy now,bulls back to loading for run again
👍️0
skichic skichic 1 year ago
Oppenheimer has a buy rating of Overweight for CLNN and a price target of $20.00!
👍️0
skichic skichic 1 year ago
Strange how CLNN traded today. Fantastic news, huge insider buy and the shorts controlled. Absolutely crazy. I added to my stash big time!
👍️0
81vette 81vette 1 year ago
Bills have to get paid,maybe done in after mkt for continued this year long up trend,
👍️0
TheFinalCD TheFinalCD 1 year ago
ALL DAY FADER= ZZZZZZZZZ
👍️0
81vette 81vette 1 year ago
todays news>https://capedge.com/news/benzinga/30873738/clene-reports-new-data?fromCompany=1822791
👍️0
81vette 81vette 1 year ago
zero borrow>no shares available to short(float locked up),insider buys up 400%,recient news coverage blowing up,283Xs ave vol will get attention today
👍️0
81vette 81vette 1 year ago
#1 on my scanner>Strong Volume Gainer,New CCI Buy Signals,Parabolic SAR Buy Signals,Gap Ups,Filled Black Candles,Elder Bar Turned Green
👍️0
81vette 81vette 1 year ago
#1 on my scanner>Strong Volume Gainer,New CCI Buy Signals,Parabolic SAR Buy Signals,Gap Ups,Filled Black Candles,Elder Bar Turned Green
👍️0
81vette 81vette 1 year ago
Shares Outstanding 63.51M,Shares Float 27.20M,Institutional Ownership 6.00%,Insider Ownership 8.80%,Short Float 6.74%
👍️0
harry crumb harry crumb 1 year ago
Any reason this is active other than form 4’s filed? Their lead science candidate failed
👍️0
tw0122 tw0122 1 year ago
At least you got the board opened flipped it once already when it went under $2 $1.95 to $2.17. Maybe will try one more time on a pullback..
👍️0
TheFinalCD TheFinalCD 1 year ago
https://clene.com/pipeline/
👍️0
TheFinalCD TheFinalCD 1 year ago
https://finviz.com/quote.ashx?t=CLNN&ty=c&ta=1&p=d
👍️0

Your Recent History

NASDAQ
CLNN
Clene
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved